OssDsign PROPEL spine fusion registry tops 400 patients for Catalyst bone graft study
Reuters2026/09/09 07:59- OssDsign reported PROPEL, a real-world spine fusion registry for its Catalyst bone graft, has enrolled more than 400 patients.
- Results were already presented from an earlier subset of patients, showing strong fusion outcomes in a complex, high-risk population.
- Patients also recorded broad health improvements, with no product-related safety issues flagged in the published analysis.
- The larger enrollment strengthens the company’s clinical evidence base, supporting commercial positioning against other graft options in spine surgery.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Over $70 billions amassed in a single day, reaching a new high since June! Global companies rush to issue bonds ahead of the Federal Reserve rate hike
After setting a new record on Tuesday for the busiest global issuance day since June, with total fundraising exceeding 70 billions of dollars, companies are accelerating their return to the bond market. They aim to lock in funds before borrowing costs rise any further.
K2 Gold drills 27.43 m at 4.08 g/t gold at Mojave Dragonfly zone in California
GT Resources samples 5.6 g/t gold at CD project schist target in Yukon
Crypto prices
More
